Jill DeSimone is a director of Praxis Precision Medicines Inc.
Person profile
Roles
Praxis Precision Medicines
Director
Oncternal Therapeutics
Director
Address
Boston, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Kinnate Biopharma Inc.
5 Apr 24
4
iTeos Therapeutics, Inc.
7 Mar 24
3
iTeos Therapeutics, Inc.
7 Mar 24
4
Praxis Precision Medicines, Inc.
10 Oct 23
4
Oncternal Therapeutics, Inc.
30 Jun 23
4
Praxis Precision Medicines, Inc.
14 Jun 23
4
Kinnate Biopharma Inc.
3 Mar 23
3
Kinnate Biopharma Inc.
3 Mar 23
4
Oncternal Therapeutics, Inc.
5 Jan 23
3
Oncternal Therapeutics, Inc.
5 Jan 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.21 | 50,000 | 260.50 k | 0 |
7 Mar 24 | ITOS ITeos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 11.58 | 44,766 | 518.39 k | 44,766 |
5 Oct 23 | PRAX Praxis Precision Medicines | Common Stock | Buy | Acquire P | No | No | 1.75 | 14,500 | 25.38 k | 14,500 |
28 Jun 23 | ONCT Oncternal Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 0.3553 | 25,000 | 8.88 k | 25,000 |